Fused Benzoisoxazolyl Compounds as KAT6A Inhibitors
Summary
The European Patent Office published patent application EP4448109A1 for fused benzoisoxazolyl compounds as KAT6A inhibitors, filed jointly by Aurigene Oncology Limited and Olema Pharmaceuticals, Inc. The invention covers heterocyclic antineoplastic compounds classified under A61P 35/00 and C07D 498/04. The patent is designated for all European Patent Convention contracting states.
What changed
The European Patent Office published patent application EP4448109A1, filed by Aurigene Oncology Limited and Olema Pharmaceuticals, Inc., covering fused benzoisoxazolyl compounds as KAT6A inhibitors for antineoplastic applications. The compounds are classified under IPC categories A61P 35/00, A61P 35/02, C07D 498/04, and A61K 31/42.
Competitors developing KAT6A-targeted oncology therapies should review the patent claims for potential freedom-to-operate concerns. The patent designation across all EPC contracting states means protection extends across the major European pharmaceutical markets including Germany, France, the United Kingdom, and other EU member states.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS
Publication EP4448109A1 Kind: A1 Apr 08, 2026
Applicants
Aurigene Oncology Limited, Olema Pharmaceuticals, Inc.
Inventors
VENKATESHAPPA, Chandregowda, BERA, Kalisankar, ABBINENI, Chandrasekhar, SAMAJDAR, Susanta, MYLES, David C., HEARN, Brian R.
IPC Classifications
A61P 35/00 20060101AFI20230624BHEP A61P 35/02 20060101ALI20230624BHEP C07D 498/04 20060101ALI20230624BHEP A61K 31/42 20060101ALI20230624BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.